Visualitza per autor "Cardoso, Fatima"
Ara mostrant els elements 1-4 d 4
-
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial
Cardoso, Fatima; Cortés Castan, Javier; Musolino, Antonio; Saura Manich, Cristina; Rugo, Hope; Curigliano, Giuseppe; Im, Seock-Ah (American Medical Association, 2021-04) -
Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology
Giuliani, Rosa; Tabernero Caturla, Josep; Cardoso, Fatima; McGregor, Keith Hanson; Vyas, Malvika; de Vries, Elisabeth (BMJ, 2019-03-06) -
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial
Cardoso, Fatima; Cortés Castan, Javier; Musolino, Antonio; Escriva de Romaní Muñoz, Santiago Ignacio; Saura Manich, Cristina; Rugo, Hope; Curigliano, Giuseppe; Im, Seock-Ah (American Society of Clinical Oncology, 2023-01-10) -
The impact of COVID-19 on cancer care and oncology clinical research: an experts’ perspective
Sessa, C.; Cortés Castan, Javier; Conte, P.; Cardoso, Fatima; Choueiri, T.; Dummer, R.; Tabernero Caturla, Josep (Elsevier, 2022-02)